Why Transparent Pricing Matters for Long-Term Weight Management
Understanding 1.7mg Wegovy vs Mounjaro Without Hidden Fee Anxiety
When comparing 1.7mg Wegovy vs Mounjaro, the biggest frustration patients face is discovering hidden charges after selecting their treatment. Many online pharmacies advertise low medication prices, then add consultation fees (£20-50), prescription charges (£15-30), or admin costs at checkout. At EverydayMeds, our £139.99 for Wegovy 1.7mg includes absolutely everything: clinical assessment, prescriber review, prescription processing, and temperature-controlled next-day delivery. This transparent approach eliminates the anxiety of unexpected costs when you're already investing significantly in your long-term weight management journey.
The 1.7mg dose represents a crucial stage in your Wegovy escalation - weeks 13-16 where many patients experience accelerated results. Comparing this to Mounjaro's equivalent phase shouldn't require calculator gymnastics to understand true costs. Both medications are available through our GPhC-registered pharmacy (#9012878) with identical pricing transparency, allowing you to focus on clinical suitability rather than hidden fee concerns.
Complete Pricing Breakdown: 1.7mg Wegovy vs Mounjaro Investment
EverydayMeds' pricing for both 1.7mg Wegovy vs Mounjaro treatments reflects our commitment to radical transparency. Your £139.99 investment covers the complete service: 3-minute online clinical assessment, prescriber review (standard 3 working days, express 24 hours available), prescription generation, and next-day cold-chain delivery to maintain medication efficacy. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access these rates. Unlike competitors who charge separate consultation fees of £20-50 plus prescription charges, our single price eliminates financial surprises.
For patients planning their transition to maintenance, our Elevate Duo bundle (1.7mg + 2.4mg) costs £369.99 - providing both your current dose and next maintenance dose with Reliable Supply continuity. This strategic approach suits the 1.7mg stage where you're planning long-term treatment sustainability. The Consistency 1.7mg bundle (two 1.7mg pens) at £309.99 offers extended supply security if your prescriber recommends staying at this dose longer before progressing.
Clinical Evidence Behind 1.7mg Wegovy vs Mounjaro Comparison
The STEP trial programme (Wilding et al., NEJM, 2021) demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1. The 1.7mg dose represents the penultimate escalation step, where many patients report noticeable appetite reduction and improved satiety signals. Mounjaro's SURMOUNT trials showed similar efficacy through its dual GIP + GLP-1 mechanism, though direct comparison isn't appropriate due to different trial designs and populations.
Both medications require prescription oversight and clinical monitoring, which our transparent pricing structure supports without additional consultation charges. The evidence suggests that reaching therapeutic doses like 1.7mg marks a turning point in treatment response, making this comparison stage particularly important for long-term success planning.
How Wegovy's 1.7mg Mechanism Differs from Mounjaro
Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics your body's natural incretin hormone to promote satiety and reduce appetite through brain appetite centres. At the 1.7mg dose, you're approaching near-maximum GLP-1 activation, with 2.4mg representing the standard maintenance level. Mounjaro uses tirzepatide, a dual GIP + GLP-1 receptor agonist that activates both incretin pathways simultaneously. This mechanistic difference means both medications work through related but distinct pathways to support weight management alongside a reduced-calorie diet and increased physical activity. The choice between these approaches depends on individual response patterns and clinical factors your prescriber will assess.
Streamlined Ordering Process for 1.7mg Wegovy vs Mounjaro Selection
Our transparent ordering eliminates the confusion many patients experience when comparing 1.7mg Wegovy vs Mounjaro options online. Complete the 3-minute clinical assessment indicating your current dose stage and treatment history, then our prescribers review your suitability for either medication within 3 working days (express 24-hour review available). Once approved, your chosen treatment ships via next-day cold-chain delivery to maintain the 2-8°C storage requirements both medications require before first use. The entire process from assessment to delivery maintains complete price transparency - no surprise charges or hidden consultation fees that disrupt your treatment budget planning.
Storage Advantages When Choosing 1.7mg Wegovy vs Mounjaro
One practical consideration in the 1.7mg Wegovy vs Mounjaro decision involves storage flexibility after removal from refrigeration. Wegovy maintains potency for up to 6 weeks at room temperature below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature stability. This storage advantage particularly benefits patients who travel frequently or have limited refrigeration access during the 1.7mg escalation phase. Both medications use pre-filled injection pens (Wegovy's FlexTouch system), but the extended room temperature stability may influence your choice if lifestyle factors are important. Your EverydayMeds prescriber can discuss these practical considerations during the clinical review process without additional consultation charges.
Long-Term Cost Planning for 1.7mg Wegovy vs Mounjaro Treatment
Reaching the 1.7mg stage means you're planning long-term weight management, making transparent pricing essential for sustainable treatment. Unlike pharmacies that use low initial prices then add hidden charges, our upfront pricing allows accurate budgeting for your maintenance phase. The Elevate Duo bundle transitioning from 1.7mg to 2.4mg costs £369.99 total - providing clear pathway planning without surprise charges disrupting your treatment continuity. Returning customers maintain access to optimal pricing through the DOSE25 code, recognising that long-term weight management requires financial sustainability alongside clinical efficacy.
This transparent approach particularly matters when comparing 1.7mg Wegovy vs Mounjaro for extended treatment periods. Both medications typically require ongoing use for sustained benefits, making hidden fee structures particularly problematic for long-term patients. Our single-price model eliminates the consultation fee trap that catches patients when reordering, ensuring your weight management investment remains predictable and sustainable.
Expert Support for Your 1.7mg Wegovy vs Mounjaro Decision
Making the right choice between 1.7mg Wegovy vs Mounjaro requires expert clinical guidance without the barrier of hidden consultation charges. Our GPhC-registered prescribers (#9012878) provide comprehensive assessment and ongoing support as part of your treatment cost, not as an expensive add-on service. Both Wegovy and Mounjaro are available from EverydayMeds with identical pricing transparency, allowing clinical factors rather than fee structures to guide your treatment selection. Whether you're continuing Wegovy escalation to maintenance or considering a switch to Mounjaro's dual-mechanism approach, our prescribers help optimise your treatment path. This expert support continues throughout your treatment journey, maintaining the same transparent pricing structure that eliminates the hidden charges plaguing other online pharmacy services.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
